SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.
Nature Communications
Xue, Yibo Y; Morris, Jordan L JL; Yang, Kangning K; Fu, Zheng Z; Zhu, Xianbing X; Johnson, Fraser F; Meehan, Brian B; Witkowski, Leora L; Yasmeen, Amber A; Golenar, Tunde T; Coatham, Mackenzie M; Morin, Geneviève G; Monast, Anie A; Pilon, Virginie V; Fiset, Pierre Olivier PO; Jung, Sungmi S; Gonzalez, Anne V AV; Camilleri-Broet, Sophie S; Fu, Lili L; Postovit, Lynne-Marie LM; Spicer, Jonathan J; Gotlieb, Walter H WH; Guiot, Marie-Christine MC; Rak, Janusz J; Park, Morag M; Lockwood, William W; Foulkes, William D WD; Prudent, Julien J; Huang, Sidong S